Affinity Capture-Migration/Separation Technologies for Investigating Post-Acute SARS-CoV-2 Persistence and Candidate Biomarkers of Long COVID

The management of COVID-19 continues to evolve as clinical experience and scientific research refine approaches to diagnosis, isolation protocols, and treatment. Diagnosing COVID-19 relies on either molecular tests to detect specific viral genetic material or antigen tests to detect viral proteins. Molecular tests generally have higher analytical sensitivity and accuracy than antigen tests, particularly early in infection. The SARS-CoV-2 RNA genetic material may remain detectable for prolonged periods after infection. Immunoassay antigen tests detect specific viral proteins but are less sensitive than molecular tests and can miss early infection. Laboratory diagnosis of acute COVID-19 commonly relies on molecular or antigen testing of respiratory specimens, including nasopharyngeal or other appropriate specimens. Both molecular and antigen tests may yield false-negative results due to insufficient viral load in the nasopharynx or false-positive results caused by sample contamination or cross-reactivity. Sputum can provide a complementary respiratory specimen, particularly in patients with productive cough; reported detection advantages depend on the sampling time, comparator specimen and assay. Pretreatment of sputum with surfactants and proteolytic enzymes effectively breaks down the sample to release viral antigens. Its effects on antigen recovery and assay interference require validation for the selected target and test. Prolonged detection of viral components has been reported, but their detection does not establish replication-competent virus. This preparation method is simple and uses small sample volumes. This narrative review explores how affinity capture-migration and affinity capture-separation techniques could use sputum and other biological fluid samples to investigate the long-term effects of COVID-19, which can lead to long-lasting multi-organ issues, as well as the impact of quantifying pro-inflammatory cytokines and aberrant glycoproteins in the lingering inflammation after COVID-19 infection. A search was conducted in Google, PubMed (MEDLINE), and Web of Science, using sputum proteomics, immunoassay testing, affinity capture-separation techniques, aberrant glycans, pro-inflammatory cytokines, COVID-19 and Long COVID as keywords, primarily selecting the most referenced and related papers of the last decade. Because post-acute sequelae of SARS-CoV-2 can afflict any individual post-infection—including pediatric populations—advancing robust analytical platforms like affinity capture-separation is vital for clearer diagnostic resolution. This narrative review article underscores the critical need for diagnostic techniques that transcend the limitations of traditional rapid antigen and molecular tests for COVID-19 and Long COVID. We highlight affinity capture-separation techniques as a promising complementary approach. Affinity capture–separation can enrich and resolve selected cytokines, proteins, glycoproteins and glycans. Its application to candidate Long COVID biomarkers is promising but is not a clinically validated diagnostic use. If validated, these platforms could offer a more comprehensive approach to evaluating systemic inflammation in severe COVID-19 and Long COVID patients.

Authors

Publication Details

Journal
Medical Sciences
Published
2026-11-16
DOI
https://doi.org/10.3390/medsci14070787
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Affinity Capture-Migration/Separation Technologies for Investigating Post-Acute SARS-CoV-2 Persistence and Candidate Biomarkers of Long COVID

Norberto A. Guzman, Sergey N. Krylov, Clifford M. Berck
Medical Sciences
Long-Term Effects of COVID-19
article

Affinity Capture-Migration/Separation Technologies for Investigating Post-Acute SARS-CoV-2 Persistence and Candidate Biomarkers of Long COVID

Norberto A. Guzman, Sergey N. Krylov, Clifford M. Berck
article en

Abstract

The management of COVID-19 continues to evolve as clinical experience and scientific research refine approaches to diagnosis, isolation protocols, and treatment. Diagnosing COVID-19 relies on either molecular tests to detect specific viral genetic material or antigen tests to detect viral proteins. Molecular tests generally have higher analytical sensitivity and accuracy than antigen tests, particularly early in infection. The SARS-CoV-2 RNA genetic material may remain detectable for prolonged periods after infection. Immunoassay antigen tests detect specific viral proteins but are less sensitive than molecular tests and can miss early infection. Laboratory diagnosis of acute COVID-19 commonly relies on molecular or antigen testing of respiratory specimens, including nasopharyngeal or other appropriate specimens. Both molecular and antigen tests may yield false-negative results due to insufficient viral load in the nasopharynx or false-positive results caused by sample contamination or cross-reactivity. Sputum can provide a complementary respiratory specimen, particularly in patients with productive cough; reported detection advantages depend on the sampling time, comparator specimen and assay. Pretreatment of sputum with surfactants and proteolytic enzymes effectively breaks down the sample to release viral antigens. Its effects on antigen recovery and assay interference require validation for the selected target and test. Prolonged detection of viral components has been reported, but their detection does not establish replication-competent virus. This preparation method is simple and uses small sample volumes. This narrative review explores how affinity capture-migration and affinity capture-separation techniques could use sputum and other biological fluid samples to investigate the long-term effects of COVID-19, which can lead to long-lasting multi-organ issues, as well as the impact of quantifying pro-inflammatory cytokines and aberrant glycoproteins in the lingering inflammation after COVID-19 infection. A search was conducted in Google, PubMed (MEDLINE), and Web of Science, using sputum proteomics, immunoassay testing, affinity capture-separation techniques, aberrant glycans, pro-inflammatory cytokines, COVID-19 and Long COVID as keywords, primarily selecting the most referenced and related papers of the last decade. Because post-acute sequelae of SARS-CoV-2 can afflict any individual post-infection—including pediatric populations—advancing robust analytical platforms like affinity capture-separation is vital for clearer diagnostic resolution. This narrative review article underscores the critical need for diagnostic techniques that transcend the limitations of traditional rapid antigen and molecular tests for COVID-19 and Long COVID. We highlight affinity capture-separation techniques as a promising complementary approach. Affinity capture–separation can enrich and resolve selected cytokines, proteins, glycoproteins and glycans. Its application to candidate Long COVID biomarkers is promising but is not a clinically validated diagnostic use. If validated, these platforms could offer a more comprehensive approach to evaluating systemic inflammation in severe COVID-19 and Long COVID patients.

Medical SciencesVol. 14(7)
Good health and well-being
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon